Literature DB >> 35113194

Circulating trimethylamine N-oxide levels following fish or seafood consumption.

Zeneng Wang1, W H Wilson Tang1,2, Thomas O'Connell3,4, Erwin Garcia3,5, Elias J Jeyarajah3, Xinmin S Li1, Xun Jia1, Taylor L Weeks1, Stanley L Hazen6,7.   

Abstract

PURPOSE: Some species of fish and seafood are high in trimethylamine N-oxide (TMAO), which accumulates in muscle where it protects against pressure and cold. Trimethylamine (TMA), the metabolic precursor to TMAO, is formed in fish during bacterial spoilage. Fish intake is promoted for its potential cardioprotective effects. However, numerous studies show TMAO has pro-atherothrombotic properties. Here, we determined the effects of fish or seafood consumption on circulating TMAO levels in participants with normal renal function.
METHODS: TMAO and omega-3 fatty acid content were quantified across multiple different fish or seafood species by mass spectrometry. Healthy volunteers (n = 50) were recruited for three studies. Participants in the first study consented to 5 consecutive weekly blood draws and provided dietary recall for the 24 h preceding each draw. In the second study, TMAO levels were determined following defined low and high TMAO diets. Finally, participants consumed test meals containing shrimp, tuna, fish sticks, salmon or cod. TMAO levels were quantified by mass spectrometry in blood collected before and after dietary challenge.
RESULTS: TMAO + TMA content varied widely across fish and seafood species. Consumption of fish sticks, cod, and to a lesser extent salmon led to significant increases in circulating TMAO levels. Within 1 day, circulating TMAO concentrations in all participants returned to baseline levels.
CONCLUSIONS: We conclude that some fish and seafood contain high levels of TMAO, and may induce a transient elevation in TMAO levels in some individuals. Selection of low TMAO content fish is prudent for subjects with elevated TMAO, cardiovascular disease or impaired renal function.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Cardiovascular disease risk; Fish consumption; Gut microbiome; Thrombosis; Trimethylamine N-oxide

Mesh:

Substances:

Year:  2022        PMID: 35113194      PMCID: PMC9283263          DOI: 10.1007/s00394-022-02803-4

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   4.865


  31 in total

1.  Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.

Authors:  Zeneng Wang; Adam B Roberts; Jennifer A Buffa; Bruce S Levison; Weifei Zhu; Elin Org; Xiaodong Gu; Ying Huang; Maryam Zamanian-Daryoush; Miranda K Culley; Anthony J DiDonato; Xiaoming Fu; Jennie E Hazen; Daniel Krajcik; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Cell       Date:  2015-12-17       Impact factor: 41.582

2.  Metabolic products of the intestinal microbiome and extremes of atherosclerosis.

Authors:  Chrysi Bogiatzi; Gregory Gloor; Emma Allen-Vercoe; Gregor Reid; Ruth G Wong; Bradley L Urquhart; Vincent Dinculescu; Kelsey N Ruetz; Thomas J Velenosi; Michael Pignanelli; J David Spence
Journal:  Atherosclerosis       Date:  2018-04-17       Impact factor: 5.162

3.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

Authors:  W H Wilson Tang; Zeneng Wang; Bruce S Levison; Robert A Koeth; Earl B Britt; Xiaoming Fu; Yuping Wu; Stanley L Hazen
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

4.  Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.

Authors:  Weifei Zhu; Jill C Gregory; Elin Org; Jennifer A Buffa; Nilaksh Gupta; Zeneng Wang; Lin Li; Xiaoming Fu; Yuping Wu; Margarete Mehrabian; R Balfour Sartor; Thomas M McIntyre; Roy L Silverstein; W H Wilson Tang; Joseph A DiDonato; J Mark Brown; Aldons J Lusis; Stanley L Hazen
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

5.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.

Authors:  Zeneng Wang; Elizabeth Klipfell; Brian J Bennett; Robert Koeth; Bruce S Levison; Brandon Dugar; Ariel E Feldstein; Earl B Britt; Xiaoming Fu; Yoon-Mi Chung; Yuping Wu; Phil Schauer; Jonathan D Smith; Hooman Allayee; W H Wilson Tang; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Nature       Date:  2011-04-07       Impact factor: 49.962

Review 6.  Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.

Authors:  Gabriele Giacomo Schiattarella; Anna Sannino; Evelina Toscano; Giuseppe Giugliano; Giuseppe Gargiulo; Anna Franzone; Bruno Trimarco; Giovanni Esposito; Cinzia Perrino
Journal:  Eur Heart J       Date:  2017-10-14       Impact factor: 29.983

7.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.

Authors:  Robert A Koeth; Zeneng Wang; Bruce S Levison; Jennifer A Buffa; Elin Org; Brendan T Sheehy; Earl B Britt; Xiaoming Fu; Yuping Wu; Lin Li; Jonathan D Smith; Joseph A DiDonato; Jun Chen; Hongzhe Li; Gary D Wu; James D Lewis; Manya Warrier; J Mark Brown; Ronald M Krauss; W H Wilson Tang; Frederic D Bushman; Aldons J Lusis; Stanley L Hazen
Journal:  Nat Med       Date:  2013-04-07       Impact factor: 53.440

Review 8.  Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose-response meta-analysis.

Authors:  Mahdieh Abbasalizad Farhangi; Mahdi Vajdi; Mohammad Asghari-Jafarabadi
Journal:  Nutr J       Date:  2020-07-30       Impact factor: 3.271

Review 9.  The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.

Authors:  Marius Trøseid; Geir Øystein Andersen; Kaspar Broch; Johannes Roksund Hov
Journal:  EBioMedicine       Date:  2020-02-12       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.